Susquehanna International Group, LLP Novartis Ag Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Novartis Ag stock. As of the latest transaction made, Susquehanna International Group, LLP holds 5,074 shares of NVS stock, worth $659,772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,074
Previous 287,686
98.24%
Holding current value
$659,772
Previous $32.1 Million
98.09%
% of portfolio
0.0%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding NVS
# of Institutions
1,558Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.38 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.35 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.18 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$983 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$926 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $280B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...